BriaCell Therapeutics Corp. (BCTX) Other Non-Current Assets (2024 - 2026)
BriaCell Therapeutics (BCTX) posted Other Non-Current Assets of $405085.0 for Q2 2026, little changed sequentially from $405085.0 in Q1 2026, and down 66.58% YoY from $1.2 million in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Other Non-Current Assets (2024 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Other Non-Current Assets for 3 years, with the latest figure at $405085.0 in Q2 2026.
- Quarterly Other Non-Current Assets fell 66.58% year-over-year to $405085.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $405085.0 (down 66.58% YoY) and the FY2025 annual result came in at $717508.0, down 40.8% from the prior year.
- Other Non-Current Assets held at $405085.0 in Q2 2026 per BCTX's latest filing, from $405085.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.2 million in Q3 2024 and troughed at $405085.0 in Q1 2026.
- A 3-year average of $886621.2 and a median of $964727.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets plunged 40.8% in 2025, then plunged 66.58% in 2026.
- Over 3 years, Other Non-Current Assets stood at $1.2 million in 2024, then slumped by 40.8% to $717508.0 in 2025, then plunged by 43.54% to $405085.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $405085.0, $405085.0, and $717508.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 405,085.00 |
| Jan 31, 2026 | 405,085.00 |
| Oct 31, 2025 | 717,508.00 |
| Jul 31, 2025 | 717,508.00 |
| Apr 30, 2025 | 1.21 Mn |
| Jan 31, 2025 | 1.21 Mn |
| Oct 31, 2024 | 1.21 Mn |
| Jul 31, 2024 | 1.21 Mn |